The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Blood-based biomarkers in metastatic colorectal cancer patients treated with FOLFIRI plus regorafenib or placebo: Results from LCCC1029.
 
Yingmiao Liu
No Relationships to Disclose
 
Kirsten Burdett
No Relationships to Disclose
 
Mark D. Starr
No Relationships to Disclose
 
J. Chris Brady
No Relationships to Disclose
 
Ace Joseph Hatch
Employment - Alnylam (I); Pearl Therapeutics (I)
 
Anastasia Ivanova
No Relationships to Disclose
 
Dominic T. Moore
No Relationships to Disclose
 
Kelli Hammond
No Relationships to Disclose
 
Michael Sangmin Lee
Consulting or Advisory Role - AstraZeneca; Bayer
Research Funding - Amgen; Bristol-Myers Squibb; EMD Serono; Genentech/Roche; Pfizer
 
Bert O'Neil
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Genentech/Roche; Merck
Speakers' Bureau - Celgene
Travel, Accommodations, Expenses - Bayer; Merck KGaA
 
Federico Innocenti
Patents, Royalties, Other Intellectual Property - Royalties from the Mayo Foundation on the UGT1A1 testing
 
Kouros Owzar
No Relationships to Disclose
 
Hanna Kelly Sanoff
Research Funding - Bayer (Inst); Merck (Inst)
 
Andrew B. Nixon
Consulting or Advisory Role - Kanghong Pharma; Lilly; Pfizer
Research Funding - Acceleron Pharma; Amgen; AstraZeneca/MedImmune; Eureka Therapeutics; Genentech/Roche; Leadiant Biosciences; medpacto; Novartis; Seagen; TRACON Pharma
Patents, Royalties, Other Intellectual Property - Patent (Inst); Patent Pending (Inst)
Travel, Accommodations, Expenses - TRACON Pharma